Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen.

Herta CrauwelsO OsiyemiC ZorrillaC BicerK Brown

Published in: HIV medicine (2019)

In view of markedly reduced darunavir and cobicistat exposures during pregnancy, this combination is not recommended in HIV-1-infected pregnant women.

Keyphrases

hiv infected
pregnant women
hiv infected patients
antiretroviral therapy
human immunodeficiency virus
air pollution
hepatitis c virus